EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Evolution of therapeutic approaches for atopic dermatitis: a comparative analysis of current clinical guidelines

Marianna B. Drozhdina, Elena V. Suslova, Varvara A. Lazviashvili, Lada A. Zapivakhina, Nikita S. Dekusar

Vestnik dermatologii i venerologii · 2026-09-29 · 102 (4) · 25-32

DOI: 10.25208/vdv17032 ↗
AbstractBibliografische Angaben

Abstract

The management of atopic dermatitis has evolved significantly in recent years due to the introduction of targeted biologics, Janus kinase (JAK) inhibitors, and novel topical therapies. This rapid progress necessitates regular updates to clinical guidelines and the revision of existing treatment algorithms. This review provides a comparative analysis of current clinical guidelines for the diagnosis and management of atopic dermatitis published between 2024 and 2025 in Japan, Canada, Korea, Europe, and Russia. Common trends were identified, and specific features in national approaches were highlighted. The analysis revealed that all reviewed guidelines reflect a paradigm shift from a predominantly stepwise treatment model to a personalized management strategy. This approach considers disease severity and extent, anatomic location, pruritus severity, impact on quality of life, patient age, comorbidities, and prior treatment response. While topical corticosteroids remain the cornerstone for managing acute flares, there is an increasing emphasis on topical nonsteroidal agents, maintenance regimens, and proactive therapy. For moderate-to-severe atopic dermatitis, advanced systemic targeted therapies, including biologics and JAK inhibitors, now occupy a central role. However, national guidelines diverge regarding specific diagnostic criteria, treatment sequencing, and recommendations for systemic corticosteroid use. These discrepancies are largely driven by regional healthcare standards and variations in drug accessibility. Thus, current guidelines demonstrate a shared focus on personalizing treatment, achieving long-term disease control, and improving patient quality of life.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →